Lee's Pharmaceutical Holdings Limited provided earnings guidance for the six months ended 30 June 2023. For the period, the Group is expected to record an unaudited net profit attributable to the Shareholders of between HKD 12 million and HKD 17 million for the six months ended 30 June 2023 as compared with approximately HKD 28 million recorded for the six months ended 30 June 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.21 HKD | +0.83% | +3.42% | -20.92% |
04-19 | Lee’s Pharmaceutical's 2023 Profit Slumps 67% | MT |
03-26 | Lee's Pharmaceutical Holdings Limited Proposes Ordinary Final Dividend for the Year Ended 31 December 2023, Payable on 17 June 2024 | CI |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.92% | 91.25M | |
+56.86% | 815B | |
+43.90% | 641B | |
-6.57% | 352B | |
+17.32% | 314B | |
+9.94% | 303B | |
+16.08% | 242B | |
+2.29% | 224B | |
+13.96% | 218B | |
+7.98% | 168B |
- Stock Market
- Equities
- 950 Stock
- News Lee's Pharmaceutical Holdings Limited
- Lee's Pharmaceutical Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023